Literature DB >> 18481452

NOD/Shi-scid IL2rgamma(null) (NOG) mice more appropriate for humanized mouse models.

M Ito1, K Kobayashi, T Nakahata.   

Abstract

"Humanized mice," in which various kinds of human cells and tissues can be engrafted and retain the same functions as in humans, are extremely useful because human diseases can be studied directly. Using the newly combined immunodeficient NOD-scid IL2rgamma(null) mice and Rag2(null) IL2rgamma(null) humanized mice, it has became possible to expand applications because various hematopoietic cells can be differentiated by human hematopoietic stem cell transplantation, and the human immune system can be reconstituted to some degree. This work has attracted attention worldwide, but the development and use of immunodeficient mice in Japan are not very well known or understood. This review describes the history and characteristics of the NOD/Shi-scid IL2rgamma(null) (NOG) and BALB/cA-Rag2(null) IL2rgamma(null) mice that were established in Japan, including our unpublished data from researchers who are currently using these mice. In addition, we also describe the potential development of new immunodeficient mice that can be used as humanized mice in the future.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18481452     DOI: 10.1007/978-3-540-75647-7_3

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  46 in total

Review 1.  HIV-1 immunopathogenesis in humanized mouse models.

Authors:  Liguo Zhang; Lishan Su
Journal:  Cell Mol Immunol       Date:  2012-04-16       Impact factor: 11.530

2.  Achieving stable human stem cell engraftment and survival in the CNS: is the future of regenerative medicine immunodeficient?

Authors:  Aileen J Anderson; Daniel L Haus; Mitra J Hooshmand; Harvey Perez; Christopher J Sontag; Brian J Cummings
Journal:  Regen Med       Date:  2011-05       Impact factor: 3.806

3.  Novel effects of simvastatin on uterine fibroid tumors: in vitro and patient-derived xenograft mouse model study.

Authors:  Mostafa A Borahay; Kathleen Vincent; Massoud Motamedi; Elena Sbrana; Gokhan S Kilic; Ayman Al-Hendy; Darren Boehning
Journal:  Am J Obstet Gynecol       Date:  2015-03-31       Impact factor: 8.661

Review 4.  New generation humanized mice for virus research: comparative aspects and future prospects.

Authors:  Ramesh Akkina
Journal:  Virology       Date:  2013-01-05       Impact factor: 3.616

5.  Engraftment of peripheral blood mononuclear cells from systemic lupus erythematosus and antiphospholipid syndrome patient donors into BALB-RAG-2-/- IL-2Rγ-/- mice: a promising model for studying human disease.

Authors:  Danieli Andrade; Patricia B Redecha; Milena Vukelic; Xiaoping Qing; Giorgio Perino; Jane E Salmon; Gloria C Koo
Journal:  Arthritis Rheum       Date:  2011-09

Review 6.  Current humanized mouse models for studying human immunology and HIV-1 immuno-pathogenesis.

Authors:  LiGuo Zhang; Eric Meissner; JianZhu Chen; LiShan Su
Journal:  Sci China Life Sci       Date:  2010-03-07       Impact factor: 6.038

7.  Generation of knockout rats with X-linked severe combined immunodeficiency (X-SCID) using zinc-finger nucleases.

Authors:  Tomoji Mashimo; Akiko Takizawa; Birger Voigt; Kazuto Yoshimi; Hiroshi Hiai; Takashi Kuramoto; Tadao Serikawa
Journal:  PLoS One       Date:  2010-01-25       Impact factor: 3.240

8.  Transduction of human CD34+ repopulating cells with a self-inactivating lentiviral vector for SCID-X1 produced at clinical scale by a stable cell line.

Authors:  Michael R Greene; Timothy Lockey; Perdeep K Mehta; Yoon-Sang Kim; Paul W Eldridge; John T Gray; Brian P Sorrentino
Journal:  Hum Gene Ther Methods       Date:  2012-11-07       Impact factor: 2.396

Review 9.  The utilization of humanized mouse models for the study of human retroviral infections.

Authors:  Rachel Van Duyne; Caitlin Pedati; Irene Guendel; Lawrence Carpio; Kylene Kehn-Hall; Mohammed Saifuddin; Fatah Kashanchi
Journal:  Retrovirology       Date:  2009-08-12       Impact factor: 4.602

Review 10.  Deconstructing stem cell tumorigenicity: a roadmap to safe regenerative medicine.

Authors:  Paul S Knoepfler
Journal:  Stem Cells       Date:  2009-05       Impact factor: 6.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.